Open-label Clinical Trial of Niraparib Combined with Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer
Shaveta Vinayak, Sara M. Tolaney, Lee Schwartzberg, Monica Mita, Georgia McCann, Antoinette R. Tan, Andrea E. Wahner-Hendrickson, Andres Forero, Carey Anders, Gerburg M. Wulf, Patrick Dillon, Filipa Lynce, Corrine Zarwan, John K. Erban, Yinghui Zhou, Nathan Buerstatte, Julie R. Graham, Sujata Arora, Bruce J. Dezube, Melinda L. Telli
Producción científica: Article › revisión exhaustiva
Profundice en los temas de investigación de 'Open-label Clinical Trial of Niraparib Combined with Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer'. En conjunto forman una huella única.